Read our latest research below
Strong Sell on Tactile Systems: Part II
This report expresses the author’s opinions. The author of this report has a short position in TCMD that will benefit from a decline in the price of TCMD’s securities. A full disclaimer can be found at the end of this report. This is a follow-on to our initial report published in June 2020. If youContinue reading “Strong Sell on Tactile Systems: Part II”
Strong Sell On Tactile Systems (TCMD): Bloated Stock Needs Compression Therapy
Strong Sell with 70% ($15 PT) downside: Un-chastened by the reality of a limited and saturated TAM, Tactile cheats to grow. VA, Medicare, and commercial payors are catching on. Insiders are jumping ship. It’s time for investors to wake up.
Follow Us
Get new content delivered directly to your inbox.
